These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 27470516)

  • 1. Phenotypic Modulation of Smooth Muscle Cells in Atherosclerosis Is Associated With Downregulation of LMOD1, SYNPO2, PDLIM7, PLN, and SYNM.
    Perisic Matic L; Rykaczewska U; Razuvaev A; Sabater-Lleal M; Lengquist M; Miller CL; Ericsson I; Röhl S; Kronqvist M; Aldi S; Magné J; Paloschi V; Vesterlund M; Li Y; Jin H; Diez MG; Roy J; Baldassarre D; Veglia F; Humphries SE; de Faire U; Tremoli E; Odeberg J; Vukojević V; Lehtiö J; Maegdefessel L; Ehrenborg E; Paulsson-Berne G; Hansson GK; Lindeman JH; Eriksson P; Quertermous T; Hamsten A; Hedin U
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1947-61. PubMed ID: 27470516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast Growth Factor 12 Is a Novel Regulator of Vascular Smooth Muscle Cell Plasticity and Fate.
    Song SH; Kim K; Jo EK; Kim YW; Kwon JS; Bae SS; Sung JH; Park SG; Kim JT; Suh W
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1928-36. PubMed ID: 27470512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Actin-Binding Protein Drebrin Inhibits Neointimal Hyperplasia.
    Stiber JA; Wu JH; Zhang L; Nepliouev I; Zhang ZS; Bryson VG; Brian L; Bentley RC; Gordon-Weeks PR; Rosenberg PB; Freedman NJ
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):984-93. PubMed ID: 27013612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear factor of activated T cells 5 regulates vascular smooth muscle cell phenotypic modulation.
    Halterman JA; Kwon HM; Zargham R; Bortz PD; Wamhoff BR
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2287-96. PubMed ID: 21757659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncological miR-182-3p, a Novel Smooth Muscle Cell Phenotype Modulator, Evidences From Model Rats and Patients.
    Sun L; Bai Y; Zhao R; Sun T; Cao R; Wang F; He G; Zhang W; Chen Y; Ye P; Du G
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1386-97. PubMed ID: 27199451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dedicator of cytokinesis 2, a novel regulator for smooth muscle phenotypic modulation and vascular remodeling.
    Guo X; Shi N; Cui XB; Wang JN; Fukui Y; Chen SY
    Circ Res; 2015 May; 116(10):e71-80. PubMed ID: 25788409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial Myocyte Enhancer Factor 2c Inhibits Migration of Smooth Muscle Cells Through Fenestrations in the Internal Elastic Lamina.
    Lu YW; Lowery AM; Sun LY; Singer HA; Dai G; Adam AP; Vincent PA; Schwarz JJ
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1380-1390. PubMed ID: 28473437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant Protein A, a Novel Regulator for Smooth Muscle Phenotypic Modulation and Vascular Remodeling-Brief Report.
    Ran R; Cai D; King SD; Que X; Bath JM; Chen SY
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):808-814. PubMed ID: 33267655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA let-7g suppresses PDGF-induced conversion of vascular smooth muscle cell into the synthetic phenotype.
    Wang TM; Chen KC; Hsu PY; Lin HF; Wang YS; Chen CY; Liao YC; Juo SH
    J Cell Mol Med; 2017 Dec; 21(12):3592-3601. PubMed ID: 28699690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8
    Schäfer S; Gogiraju R; Rösch M; Kerstan Y; Beck L; Garbisch J; Saliba AE; Gisterå A; Hermanns HM; Boon L; Kastenmüller W; Schäfer K; Cochain C; Zernecke A
    Arterioscler Thromb Vasc Biol; 2024 Aug; 44(8):1852-1872. PubMed ID: 38868941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olfactomedin 2 Regulates Smooth Muscle Phenotypic Modulation and Vascular Remodeling Through Mediating Runt-Related Transcription Factor 2 Binding to Serum Response Factor.
    Shi N; Li CX; Cui XB; Tomarev SI; Chen SY
    Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):446-454. PubMed ID: 28062493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PDGF-DD, a novel mediator of smooth muscle cell phenotypic modulation, is upregulated in endothelial cells exposed to atherosclerosis-prone flow patterns.
    Thomas JA; Deaton RA; Hastings NE; Shang Y; Moehle CW; Eriksson U; Topouzis S; Wamhoff BR; Blackman BR; Owens GK
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H442-52. PubMed ID: 19028801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of the Ras-extracellular signal-regulated kinase 1/2 pathway is involved in smooth muscle 22 alpha-mediated suppression of vascular smooth muscle cell proliferation and neointima hyperplasia.
    Dong LH; Wen JK; Liu G; McNutt MA; Miao SB; Gao R; Zheng B; Zhang H; Han M
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):683-91. PubMed ID: 20139360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration.
    Wang Q; Huo L; He J; Ding W; Su H; Tian D; Welch C; Hammock BD; Ai D; Zhu Y
    Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1894-903. PubMed ID: 26453326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The induction of yes-associated protein expression after arterial injury is crucial for smooth muscle phenotypic modulation and neointima formation.
    Wang X; Hu G; Gao X; Wang Y; Zhang W; Harmon EY; Zhi X; Xu Z; Lennartz MR; Barroso M; Trebak M; Chen C; Zhou J
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2662-9. PubMed ID: 22922963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Smooth Muscle β-Catenin Hinders Neointima Formation After Vascular Injury.
    Riascos-Bernal DF; Chinnasamy P; Gross JN; Almonte V; Egaña-Gorroño L; Parikh D; Jayakumar S; Guo L; Sibinga NES
    Arterioscler Thromb Vasc Biol; 2017 May; 37(5):879-888. PubMed ID: 28302627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KLF13 promotes VSMCs phenotypic dedifferentiation by directly binding to the SM22α promoter.
    Yuan X; Jiang C; Xue Y; Guo F; Luo M; Guo L; Gao Y; Yuan T; Xu H; Chen H
    J Cell Physiol; 2024 May; 239(5):e31251. PubMed ID: 38634445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SM22α (Smooth Muscle Protein 22-α) Promoter-Driven IGF1R (Insulin-Like Growth Factor 1 Receptor) Deficiency Promotes Atherosclerosis.
    Sukhanov S; Higashi Y; Shai SY; Snarski P; Danchuk S; D'Ambra V; Tabony M; Woods TC; Hou X; Li Z; Ozoe A; Chandrasekar B; Takahashi SI; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2306-2317. PubMed ID: 30354209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Diaphanous Formin Signaling In Vivo Impairs Cardiovascular Development and Alters Smooth Muscle Cell Phenotype.
    Weise-Cross L; Taylor JM; Mack CP
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2374-83. PubMed ID: 26381868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardin regulates vascular response to injury through miR-24/-29a and platelet-derived growth factor receptor-β.
    Talasila A; Yu H; Ackers-Johnson M; Bot M; van Berkel T; Bennett MR; Bot I; Sinha S
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2355-65. PubMed ID: 23825366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.